SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-17-000027
Filing Date
2017-01-03
Accepted
2017-01-03 21:10:11
Documents
1
Period of Report
2017-01-01

Document Format Files

Seq Description Document Type Size
1 form4-01032017_060159.html 4  
1 form4-01032017_060159.xml 4 3875
  Complete submission text file 0001415889-17-000027.txt   5331
Mailing Address 11535 SORRENTO VALLEY ROAD SUITE 400 SAN DIEGO CA 92121
Business Address 11535 SORRENTO VALLEY ROAD SUITE 400 SAN DIEGO CA 92121 8582599405
MABVAX THERAPEUTICS HOLDINGS, INC. (Issuer) CIK: 0001109196 (see all company filings)

IRS No.: 930987903 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421
Business Address
EISENBERG JEFFREY F (Reporting) CIK: 0001224096 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37861 | Film No.: 17503440